ExL Pharmas Proof of Mechanism Decision Making for Oncology Imaging Biomarker Trials (PPMD)
|Event Date/Time: Jun 25, 2009|
1. Setting up the study for success: What considerations are critical for ensuring successful image acquisition and analysis?
2. Patient selection, sample size and lesion selection: How do you enhance the chance of making the right POM decision with a severely limited number of patients?
3. Establishing POM criteria: What are the options and how do you choose the best one?
4. Blinded and Independent reads in a severely limited study: Should we be even more careful to avoid confounding or biased results?